QUEST DIAGNOSTICS INC 8-K

What Happened

• Quest Diagnostics Incorporated filed an 8‑K on February 10, 2026 announcing its results for the quarter and full year ended December 31, 2025 (press release attached as Exhibit 99.1).
• The company’s Board authorized an additional $1.0 billion for its common stock repurchase program and approved a quarterly dividend increase from $0.80 to $0.86 per share (a 7.5% raise). The higher dividend is payable April 20, 2026 to shareholders of record as of April 6, 2026 (press release attached as Exhibit 99.2).

Key Details

• Filed: Form 8‑K dated February 10, 2026 (Items 2.02 and 8.01).
• Share repurchase: Additional authorization of $1.0 billion under the company’s repurchase program.
• Dividend: Quarterly dividend increased from $0.80 to $0.86 per share (7.5% increase); payable April 20, 2026; record date April 6, 2026.
• Results announced: Quarter and full‑year financial results for the period ended December 31, 2025 (see Exhibit 99.1 for details).

Why It Matters

• The additional $1B buyback and higher dividend are shareholder‑friendly moves that can reduce share count and increase cash returns to investors.
• The earnings release provides the latest view of Quest’s revenue and operating results for Q4 and FY2025—important inputs for evaluating growth, margins, and cash flow that support dividends and buybacks.
• Investors should review the attached press release for the specific financial figures, guidance (if any), and management commentary to assess impact on valuation, yield, and expected share dilution/repurchase pace.